Singapore, March 21, 2024 —FedExExpress (FedEx), a subsidiary of FedEx Corp. (NYSE: FDX) and one ofthe world’s largest express transportation companies, has beennamed ‘Overall Logistics & Supply Chain Management Supplier of theYear’ and also received the ‘Best Logistics & Supply ChainManagement Supplier Award: Last Mile Implementation’ at theAsia-Pacific Biopharma Excellence Awards 2024 (ABEA 2024).
Organized by IMAPAC,ABEA 2024 seeks to give recognition to exceptional bioprocessing,logistics and supply chain management, as well as clinical trialsexperts, organizations, and technologies in the Asia region.
FedEx has built its healthcare capabilities over decades, includingits dedicated healthcare team and coldchain network, to ship vaccines, biologics, and medicalaid all around the world. With a global network of more than 680aircraft and 200,000 vehicles, and four Life Science Centers in theregion including South Korea, Japan, Singapore and India, FedExenables movement of healthcare shipments usingtemperature-controlled solutions and real-time monitoringusing FedExSenseAware to help protect shipment integrity. Thecompany’s dedicated service, FedExClinical Care, provides an end-to-end shipping solutiondesigned to transport precious biological samples at the exactspeed and temperature required for safe, compliant clinicaltrials.
“The healthcare industry has very specific and carefully regulatedlogistics needs. Being recognized by voters among the biopharmacommunity is the highest possible recognition we can receive,” saidSalil Chari, senior vice president, Marketing and CustomerExperience, Asia Pacific, Middle East, and Africa Region, FedExExpress. “Our mission is to make supply chains smarter foreveryone. We are transforming to build the world’s most flexible,efficient, and intelligent logistics network by using advancedsensor-based monitoring and predictive tools to ensure criticalshipments reach their destinations safely. Our healthcare customerscan be confident our innovative solutions will meet all theirshipping needs.”
The ABEA 2024 was held in conjunction with 11th BiologicsManufacturing Asia, 8th BioLogistics World Asia and 2nd ClinicalTrials Festival Asia on 20th March 2024 in Singapore, gatheringhundreds of biopharma industry leaders. To learn more about theABEA 2024 awards, please visit.
